Overview

Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study was to determine whether clonazepam and paroxetine are effective in the treatment of panic disorder. Efficacy was evaluated in short-term, long-term and post-treatment.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Collaborator:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Treatments:
Clonazepam
Paroxetine
Criteria
Inclusion Criteria:

- Diagnosis of panic disorder, with or without agoraphobia according to the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition, text revision (DSM-IV-TR)
criteria, as determined by a structured clinical interview.

- At least two panic attacks in the week preceding their inclusion in the study.

Exclusion Criteria:

- Patients unable or unwilling to provide written informed consent.

- Did not complete all the evaluations before study initiation.

- Had comorbidities that could affect clinical evaluation including drug abuse,
neurological disorders, or severe personality disorder.